Senior Scientist – KTP Associate
Cambridge £34,000 - £40,000


Job sector
Health & Life Sciences (Healthy Living)
Job function
Diagnostics, medical technology and devices
Job duration
24 months
Application closing date
20/07/2025
Job description
We are seeking a highly motivated Research Associate to lead a 2-year collaborative project between ARU and LinkGevity Limited under the UK Government-sponsored Knowledge Transfer Partnership (KTP). This role offers an exciting opportunity to formulate and embed a first in class anti-necrotic for use in cryopreservation, augmenting our existing platform technology and supporting the development and growth of the cryopreservation sector, whilst improving hospital diagnostics, reducing invasive biopsy requirements and ensuring high-quality samples for accurate and efficient diagnostic.
The successful candidate will be responsible for undertaking research in cell culture, 3D Cell culture, cell stains and microscopy, whilst having the ability to critically analyse data using qualitative techniques.
This position offers an excellent opportunity to engage in cutting-edge research while working closely with industry partners to drive innovation, product development, and commercial impact. The role is well-suited to a researcher with experience in working with model organisms, scaling up technologies in cell culture and possessing strong problem-solving skills and a commitment to applied research.
Project description
To formulate a first in class anti-necrotic for use in cryopreservation augmenting our existing platform technology and supporting the development and growth of the cryopreservation sector, whilst improving hospital diagnostics, reducing invasive biopsy requirements and ensuring high-quality samples for accurate and efficient diagnostic.
About the business

LinkGevity Limited is a UK registered company at the forefront of longevity science, dedicated to extending healthspan and improving quality of life through innovative drug discovery and advanced AI technology. Our Anti-Necrotics™ are first-in-class necrosis inhibitors. We are developing a broad and robust pipeline covering clinical as well as non-clinical e.g. tissue engineering applications.